We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 68

Food law: quick bites and upcoming calendar
  • King & Wood Mallesons
  • Australia
  • April 30 2015

The ACCC is seeking leave to appeal the Federal Court decision dismissing its case against Pfizer for alleged misuse of market power and exclusive


Privacy Commissioner’s decision set aside by the Federal Court
  • King & Wood Mallesons
  • Australia
  • March 16 2015

A recent decision by Federal Court of Australia illustrated two things about privacy complaints - or at least those that end up before the courts:


Blockbuster drug goes bust? The Federal Court finds three AstraZeneca patents relating to Crestor (rosuvastatin) invalid
  • King & Wood Mallesons
  • Australia
  • March 7 2013

In an important decision handed down on Tuesday, Justice Jagot of the Federal Court held that three patents relating to the blockbuster drug Crestor


Australian case notes - Odisho v Bonazzi 2014 VSCA 11
  • King & Wood Mallesons
  • Australia
  • May 20 2014

In this case the appellant, a patient who suffered a thromboembolic event following the use of tranexamic acid, claimed that her doctor had


High Court grants special leave to appeal extension of time in pharmaceutical patent case
  • King & Wood Mallesons
  • Australia
  • April 15 2014

Last Friday the High Court of Australia granted Alphapharm special leave to appeal from a decision of the Full Federal Court in Aspen Pharma Pty Ltd


Experimental evidence comply with the rules or risk inadmissibility
  • King & Wood Mallesons
  • Australia
  • March 22 2013

By refusing to allow Generic Health to adduce experimental evidence in a patent case currently being heard in the Federal Court, Justice Jagot has


European Commission ups the cost of paying for delay
  • King & Wood Mallesons
  • Australia, European Union, USA
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram


Those drugs cost how much?? Chemist warehouse price list misleading but not for the reasons you might think
  • King & Wood Mallesons
  • Australia
  • October 29 2012

Last Monday the Supreme Court of Queensland held that a price list published by various Chemist Warehouse pharmacies in Cairns, Nerang, Coolangatta and other parts of Queensland was likely to mislead or deceive and therefore contravene clause 18 of the Australian Consumer Law (Competition and Consumer Act 2010 (Cth), schedule 2, section 18


The image of deception
  • King & Wood Mallesons
  • Australia
  • March 14 2014

On 10 March 2014, the Federal Court of Australia found that Breast Check Pty Ltd engaged in misleading or deceptive conduct and made false


Australian court decides important gene patenting question isolated genetic material patentable subject matter
  • King & Wood Mallesons
  • Australia
  • February 15 2013

Earlier today, the Federal Court rejected a claim brought by Cancer Voices Australia that isolated genetic material (DNA or RNA) that is naturally